The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form.

about

The Development and Validation of a Stability-Indicating UHPLC-DAD Method for Determination of Perindopril l-Arginine in Bulk Substance and Pharmaceutical Dosage Form.

Item

http://www.wikidata.org/entity/Q41879572

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The Development and Validation ...... nd Pharmaceutical Dosage Form.

@en

type

Item

label

The Development and Validation ...... nd Pharmaceutical Dosage Form.

@en

prefLabel

The Development and Validation ...... nd Pharmaceutical Dosage Form.

@en

P1476

The Development and Validation ...... and Pharmaceutical Dosage Form

@en

P2093

Alicja Talaczyńska

http://www.w3.org/2001/XMLSchema#string

Anna Krause

http://www.w3.org/2001/XMLSchema#string

Piotr Garbacki

http://www.w3.org/2001/XMLSchema#string

Przemysław Zalewski

http://www.w3.org/2001/XMLSchema#string

P2860

Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril.

Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships.

A validated stability-indicating RP-LC method for the simultaneous determination of amlodipine and perindopril in tablet dosage form and their stress degradation behavior under ICH-recommended stress conditions.

Stability-indicating RP-HPLC method for the quantitative analysis of perindopril erbumine in tablet dosage form.

Molecular structure and stability of perindopril erbumine and perindopril L-arginine complexes.

Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.

The use of microcalorimetry and HPLC for the determination of degradation kinetics and thermodynamic parameters of Perindopril Erbumine in aqueous solutions.

Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.

P2888

s10337-014-2724-7

P304

1497-1501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10337-014-2724-7

http://www.w3.org/2001/XMLSchema#string

P433

21-22

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Judyta Cielecka-Piontek

Magdalena Paczkowska

P577

2014-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268450945

http://www.w3.org/2001/XMLSchema#string

P698

25400289

http://www.w3.org/2001/XMLSchema#string

P932

4224746

http://www.w3.org/2001/XMLSchema#string